About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in California | 1,207 Studies

Clinical Trials Prostate CancerCalifornia

Prostate Cancer Clinical Trials in California

Find 1,207 clinical trials for prostate cancer near California. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in California

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 101-120 of 1,207 trials

CompletedTreatment of Prostate Cancer With Adjuvant Bevacizumab Plus ErlotinibThe purpose of this study is to evaluate the safety and effectiveness of bevacizumab plus erlotinib following radical prostatectomy.NCT00203424·Alhambra, California and 15 others Active not recruitingA Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)This Phase II study aims to evaluate the efficacy and safety of the combination of JSB462 (also known as luxdegalutamide) at 100 mg and 300 mg QD doses + lutetium (177Lu)…NCT07047118·Duarte, California and 43 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingLocally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)This is a phase 2 pragmatic study that evaluates the clinical benefit of continuing systemic therapy with the addition of locally ablative therapies for oligo-progressive solid…NCT06101290·Sacramento, California

TerminatedOrteronel in Treating Patients With Metastatic Hormone-Resistant Prostate CancerThis phase II trial studies how well orteronel works in treating patients with metastatic hormone-resistant prostate cancer.NCT01866423·Los Angeles, California

CompletedEffect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic AcidThis is an open-label exploratory study of CTAP101 Capsules in patients with bone metastases arising from either breast or prostate cancer, who are taking anti-resorptive therapy.NCT02274623·Long Beach, California and 5 others

CompletedResistance Training and Protein Supplementation for Prostate Cancer SurvivorsThis randomized pilot clinical trial studies resistance training and protein supplementation in increasing lean body mass in patients with prostate cancer receiving androgen…NCT01909440·Los Angeles, California

CompletedHigh Resolution MRI Study for Prostate CancerThis high resolution MRI (hrMRI), along with stand MRI (sMRI) will be obtained at baseline and again in approximately 1 year in patients on prostate cancer active surveillance.NCT03292874·Los Angeles, California

CompletedPlatform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel CombinationsThis study is designed to evaluate multiple clinical hypotheses and mechanistically-defined combinations to evaluate the safety and efficacy of immunotherapy combinations in…NCT03835533·Los Angeles, California and 5 others

CompletedFenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate CancerThis phase II trial is studying how well fenretinide works in treating patients with biochemically (rising PSA level) recurrent hormone-naïve (no previous hormone therapy)…NCT00080899·Los Angeles, California

TerminatedDocetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer PatientsThe primary objective of this study is to compare the duration of survival between patients receiving docetaxel in combination with the GVAX® vaccine for prostate cancer versus…NCT00133224·Anchorage, Alaska and 114 others

Not yet recruitingAnalyzing Clinical Trial Experiences of Prostate Cancer PatientsParticipation in clinical trials usually favors a particular demographic group.NCT05411354·San Francisco, California

CompletedPilot Study of Secondary Causes of Osteopenia/Osteoporosis in Adults With Breast and Prostate CancerThe investigators hypothesis is that secondary causes of bone loss are prevalent in patients with breast and prostate cancer, and those patients with secondary causes of bone loss…NCT01277562·Duarte, California

RecruitingMRI-Based Machine Learning Approach Versus Radiologist MRI Reading for the Detection of Prostate Cancer, The PRIMER TrialThis clinical trial studies how well a magnetic resonance imaging (MRI)-based machine learning approach (i.e., artificial intelligence \[AI\]) works as compared to radiologist MRI…NCT07162194·Los Angeles, California

Unknown18F-DCFPyL PET-CT Scan and Prostate CancerPrimary Objective: The primary objective of this study is to assess the efficacy of 18F-DCFPyL PET-CT for initial staging of prostate cancer in Veterans compared to conventional…NCT03852654·Los Angeles, California

Active not recruitingA Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 InactivationThe primary objective is to assess the activity and efficacy of pembrolizumab, a checkpoint inhibitor, in Veterans with metastatic castration-resistant prostate cancer (mCRPC)…NCT04104893·San Francisco, California and 12 others

TerminatedNUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid TumorsNUV-868-01 is a first-in human, open- label, Phase 1/2 dose escalation and expansion study in patients with advanced solid tumors.NCT05252390·Tucson, Arizona and 21 others

CompletedCombination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone TherapyRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00005810·San Francisco, California and 6 others

RecruitingAZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)The intention of the study is to demonstrate superiority of AZD2265 relative to standard of care treatments by assessment of radiographic progression-free survival (rPFS) and…NCT07611110·Dothan, Alabama and 131 others

CompletedImpact of Monosodium Glutamate on 68GA-PSMA-11, PET Imaging Biodistribution in Patients With Prostate CancerThis phase I trial studies the impact of monosodium glutamate (MSG) on 68GA-PSMA-11 PET/CT in decreasing the salivary glands uptake in patients with prostate cancer.NCT04282824·Los Angeles, California

CompletedTo Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) AntigenThis is a randomized, multicenter, single blind, Phase 2 trial of immunotherapy in men with metastatic androgen independent prostate cancer to evaluate sipuleucel-T manufactured…NCT00715078·La Jolla, California and 11 others

PreviousPage 6 of 61Next

Other Conditions in California

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma